Is Gadoterate Meglumine Injection in shortage?
Gadoterate Meglumine Injection is listed by FDA as being discontinued by at least one maker (updated Jun 30, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-080-05)
Marketed by Fresenius Kabi, USA; Discontinuation of the manufacture of the drug
Maker contact: 888-386-1800
- Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-082-10)
Marketed by Fresenius Kabi, USA; Discontinuation of the manufacture of the drug
Maker contact: 888-386-1800
- Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-084-15)
Marketed by Fresenius Kabi, USA; Discontinuation of the manufacture of the drug
Maker contact: 888-386-1800
- Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-086-20)
Marketed by Fresenius Kabi, USA; Discontinuation of the manufacture of the drug
Maker contact: 888-386-1800
Gadoterate Meglumine Injection shortage questions
Is Gadoterate Meglumine Injection in shortage?
Gadoterate Meglumine Injection is listed by FDA as being discontinued by at least one maker (updated Jun 30, 2026).
What should I do if I can’t get Gadoterate Meglumine Injection?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.